Skip to main content

Table 2 Laboratory tests results of the studied patients

From: High flow nasal cannula oxygen and non-invasive mechanical ventilation in management of COVID-19 patients with acute respiratory failure: a retrospective observational study

 

All patients (n=63)

HFNCO (n=37)

NIV (n=26)

P#

Hemoglobin gm/dl

13.60 ± 1.60

13.67 ± 1.56

13.50 ± 1.64

0.34

White blood cells × 109 /L

5.65 ± 2.21

5.61 ± 2.19

5.7 ± 2.23

0.44

Neutrophils %

76.69 ± 4.46

76.32 ± 4.86

77.23 ± 3.77

0.21

Lymphocytes count × 109 /L

0.74 ± 0.10

0.75 ± 0.09

0.71 ± 0.10

0.05

Platelet count × 109 /L

198.34 ± 35.81

196.45 ± 34.46

201.03 ± 37.49

0.31

Sodium mmol/L

137.28 ± 2.23

137.13 ± 2.08

137.5 ± 2.42

0.26

Potassium mmol/L

3.80 ± 0.17

3.77 ± 0.15

3.86 ± 0.19

0.02*

ALT U/L

35.98 ± 7.84

36.37 ± 8.05

35.42 ± 7.49

0.32

AST U/L

38.33 ± 11.38

38.21 ± 10.15

38.5 ± 12.94

0.46

Albumin g/dl

3.72 ± 0.25

3.77 ± 0.24

3.63 ± 0.24

0.01*

Serum creatinine mg/dl

0.81 ± 0.21

0.80 ± 0.21

0.83 ± 0.24

0.31

Blood urea nitrogen mg/dl

18.49 ± 4.89

18.29 ± 5.20

18.76 ± 4.40

0.35

ESR mm/h

67.65 ± 52.40

60.43 ± 38.79

77.93 ± 65.82

0.09

CRP mg/L

48.53 ± 20.70

49.70 ± 21.37

46.88 ± 19.59

0.30

Procalcitonin ng/ml

0.06 ± 0.02

0.06 ± 0.03

0.07 ± 0.02

0.03

  1. HFNCO high flow nasal cannula oxygen, NIV non-invasive ventilation, ALT alanine aminotransferase, AST aspartate aminotransferase, ESR erythrocyte sedimentation rate, CRP C-reactive protein
  2. #P for comparison between HFNCO and NIV, significance at *P<0.05